BRCA1: A Novel Prognostic Factor in Resected Non-Small-Cell Lung Cancer

• Rafael Rosell ,

  *To whom correspondence should be addressed. E-mail: rrosell@ico.scs.es

  Affiliation Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain

  ⨯
• Marcin Skrzypski,

  Affiliations Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain, Medical University of Gdansk, Gdansk, Poland

  ⨯
• Ewa Jassem,

  Affiliation Medical University of Gdansk, Gdansk, Poland

  ⨯
• Miquel Taron,

  Affiliation Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain

  ⨯
• Roberta Bartolucci,

  Affiliation Azienda Ospedaliera Santa Maria, Terni, Italy

  ⨯
• Jose Javier Sanchez,

  Affiliation Autonomous University of Madrid, Madrid, Spain

  ⨯
• Pedro Mendez,

  Affiliation Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain

  ⨯
• Imane Chaib,

  Affiliation Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain

  ⨯
• Laia Perez-Roca,

  Affiliation Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain

  ⨯
• Amelia Szymanowska,

  Affiliation Medical University of Gdansk, Gdansk, Poland

  ⨯
• Witold Rzyman,

  Affiliation Medical University of Gdansk, Gdansk, Poland

  ⨯
• Francesco Puma,

  Affiliation Azienda Ospedaliera Santa Maria, Terni, Italy

  ⨯
• Grazyna Kobierska-Gulida,

  Affiliation Medical University of Gdansk, Gdansk, Poland

  ⨯
• Raffaele Farabi,

  Affiliation Azienda Ospedaliera Santa Maria, Terni, Italy

  ⨯
• Jacek Jassem

  Affiliation Medical University of Gdansk, Gdansk, Poland

  ⨯